首页> 外文期刊>Therapeutic advances in respiratory disease. >Phototherapy for allergic rhinitis: a prospective, randomized, single-blind, placebo-controlled study
【24h】

Phototherapy for allergic rhinitis: a prospective, randomized, single-blind, placebo-controlled study

机译:光敏疗法治疗过敏性鼻炎:一项前瞻性,随机,单盲,安慰剂对照研究

获取原文
           

摘要

Background: Phototherapy has a profound immunosuppressive effect, and phototherapeutic methods using both ultraviolet (UV) and visible light are therefore widely used for the therapy of various inflammatory skin diseases. It is also proposed that phototherapy, using a combination of UV-A (25%), UV-B (5%) and visible light (70%), may represent a therapeutic alternative in patients with allergic rhinitis.Method: Seventy-nine patients were randomly assigned to receive either a combination of UV-A (25%), UV-B (5%) and visible light (70%), in the phototherapy group, or low-intensity visible light, in the control group. The efficacy of treatment was assessed by means of total nasal symptom score before treatment and 1 month after the end of treatment.Results: Total nasal scores decreased in both groups but the decrease was highly significant in the active treatment group when compared with the placebo (p < 0.001).Conclusions: This study demonstrates that phototherapy may be an effective modality in the treatment of allergic rhinitis especially in cases of which commonly used drugs either are contraindicated and/or have insufficient efficacy.
机译:背景:光疗具有深远的免疫抑制作用,因此同时使用紫外线(UV)和可见光的光疗方法被广泛用于治疗各种炎症性皮肤病。还建议光疗结合使用UV-A(25%),UV-B(5%)和可见光(70%),可以代表过敏性鼻炎患者的治疗选择。方法:79随机分配患者接受光疗组的UV-A(25%),UV-B(5%)和可见光(70%)的组合或对照组的低强度可见光的组合。通过治疗前和治疗结束后1个月的总鼻症状评分来评估治疗效果。结果:与安慰剂相比,两组的总鼻分数均降低,但活性治疗组的降幅非常显着( p <0.001)。结论:这项研究表明,光疗可能是治疗变应性鼻炎的一种有效方式,尤其是在禁用常用药物和/或疗效不足的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号